🇺🇸 FDA

Company profile · Sponsor

A.

A. Menarini Industrie Farmaceutiche Riunite s.r.l.

E47AD3E · EMA pharma FIRENZE, IT
Pipeline
2
Drugs
0
Patents
0

Quick answer

A. (E47AD3E) is a pharma company. headquartered in FIRENZE, IT. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E47AD3E
Exchange EMA
Company type pharma
Headquarters FIRENZE, IT

Pipeline (2)

Search pipeline →

  1. Bilaxten Flas 10 mg comprimidos bucodispersables

    A.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial

  2. Placebo, Desloratadine 5 mg orodispersible tablets, Bactil Flas 10 mg Liofilizados orales, Bilaxten 20 mg comprimidos bucodispersables

    A.

    Allergy

    approved small molecule active

    1 trial

Frequently asked questions

What is A.?

A. (E47AD3E) is a pharma company. headquartered in FIRENZE, IT. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does A. sponsor?

We track 2 ClinicalTrials.gov-linked programs for A., including Bilaxten Flas 10 mg comprimidos bucodispersables and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does A. company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.